While studies and assessments of GLP-1 AOMs, such as the cost-effectiveness study by the Institute for Clinical and Economic Review (ICER), 24 emphasize the potential for improved outcomes in obesity-related chronic diseases (e.g., heart disease, diabetes, osteoarthritis) and the potential related savings, the cost of AOMs must be paid up front, often exceeding the political or financial capacity of state legislatures to fund the program adequately
Your licensed healthcare provider then needs to submit the prior authorization request either electronically or by phone
They help regulate blood sugar levels, reduce appetite, and promote weight loss by mimicking the effects of the GLP-1 hormone in the body
Researchers conducted a prospective single-center cohort study of adults with a BMI of 27 kg/m 2 or higher using liraglutide (Victoza/Saxenda, Novo Nordisk) or semaglutide (Ozempic/Wegovy, Novo Nordisk)
Many people report fewer cravings and less constant preoccupation with food, especially as appetite regulation improves
If a medication improves lifespan but harms quality of life, it deserves attention not dismissal
